RT @JulianAlcazr: There were not sig. differences in quality of life between sarcopenic and a non-sarcopenic subjects when it was only base…
RT @JulianAlcazr: There were not sig. differences in quality of life between sarcopenic and a non-sarcopenic subjects when it was only base…
RT @JulianAlcazr: There were not sig. differences in quality of life between sarcopenic and a non-sarcopenic subjects when it was only base…
RT @JulianAlcazr: There were not sig. differences in quality of life between sarcopenic and a non-sarcopenic subjects when it was only base…
@kenmpt @jptlowy @MylesQuiben @ctmdpt have you used the SarQoL® ? https://t.co/5vurqvTx09
There were not sig. differences in quality of life between sarcopenic and a non-sarcopenic subjects when it was only based on the notion of decreased #muscle mass #Dynapenia is the true key concept! https://t.co/YgC7Dv8Ptz
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
SarQoL® was able to discriminate sarcopenic from non-sarcopenic subjects. Poorer QoL seems more related to muscle function than to muscle mass @olibruyere https://t.co/Nj2JJZnCBZ
RT @olibruyere: Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with t…
Our new paper on the impact of the use of different diagnosis definitions on quality of life in #sarcopenia measured with the SarQoL®: https://t.co/BNqToHNcun